Submission of a copy of Un- Audited Financial Statement for the Period (Q1) ended 30 September, 2024.

Dear Sir,

Please find enclosed here with a copy of Un- Audited Financial Statement  of Central Pharmaceuticals Ltd. For the period (Q1) ended 30 September, 2024. For your kind consideration .

Particulars	01-07-2024 to 30-09-2024		01-07-2023 to 30-09-2023
Net Profit After Tax(Taka)	(4,53,140)		(65,14,847)
Earnings per share (Taka)	(0.004)		(0.05)
Net Operating cash flow per share (Taka)	(0.00)		(0.00)
	As on 30.09.2024		As on 30.06.2024
Net Asset (NAV) Per Value Share (Taka)		7.05	7.06

This is for  your kind information and record.

By the order of the Board.

Thanking you